Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma

Background: The prognosis of early stage non-small cell lung cancer (NSCLC) is quite disappointing and the benefits of adjuvant therapy are relatively small. Thus, there is an urgent need to identify novel prognostic and predictive biomarkers. Lung adenocarcinoma has distinct clinical–pathological c...

Descripción completa

Detalles Bibliográficos
Autores principales: de Miguel-Pérez, Diego, Bayarri-Lara, Clara Isabel, Ortega, Francisco Gabriel, Russo, Alessandro, Moyano Rodriguez, María José, Alvarez-Cubero, Maria Jesus, Maza Serrano, Elizabeth, Lorente, José Antonio, Rolfo, Christian, Serrano, María José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896005/
https://www.ncbi.nlm.nih.gov/pubmed/31703465
http://dx.doi.org/10.3390/cancers11111750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896005/
https://www.ncbi.nlm.nih.gov/pubmed/31703465
http://dx.doi.org/10.3390/cancers11111750

Ejemplares similares